HYLQ Strategy Corp. (CSE:HYLQ)

CTI BioPharma Balance Sheet

Financials in millions CAD. Fiscal year is February - January.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2025	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Cash & Equivalents	0.08	0.26	0.24	1.64	0.19	0.02
Cash & Short-Term Investments	0.08	0.26	0.24	1.64	0.19	0.02
Cash Growth	-96.68%	6.84%	-85.23%	748.15%	689.48%	-
Accounts Receivable	-	-	-	-	-	0.08
Other Receivables	-	-	-	-	0.01	-
Receivables	-	-	-	-	0.01	0.08
Prepaid Expenses	0	-	-	-	-	0.03
Other Current Assets	-	0	0	0.01	-	-
Total Current Assets	0.08	0.26	0.24	1.65	0.2	0.13
Property, Plant & Equipment	-	-	-	-	-	0.02
Long-Term Investments	-	-	0.75	1.26	3.01	-
Total Assets	0.08	0.26	0.99	2.91	3.21	0.15
Accounts Payable	0.05	0.06	0.07	0.06	0.08	0.69
Accrued Expenses	0.22	0.54	0.21	0.44	0.13	-
Short-Term Debt	0.26	-	1.29	1.29	0.42	0.18
Current Portion of Leases	-	-	-	-	-	0.11
Current Unearned Revenue	-	-	-	-	-	0.02
Other Current Liabilities	0.34	1.03	0.51	0.33	2.48	0.2
Total Current Liabilities	0.87	1.63	2.08	2.12	3.12	1.2
Long-Term Debt	-	-	-	-	-	0.04
Total Liabilities	0.87	1.63	2.08	2.12	3.12	1.24
Common Stock	14.55	14.55	11.66	11.66	11.65	5.92
Retained Earnings	-18.69	-19.81	-14.78	-12.9	-13.45	-8.71
Comprehensive Income & Other	3.35	3.89	2.03	2.03	1.89	1.71
Shareholders' Equity	-0.79	-1.38	-1.09	0.79	0.09	-1.08
Total Liabilities & Equity	0.08	0.26	0.99	2.91	3.21	0.15
Total Debt	0.26	-	1.29	1.29	0.42	0.32
Net Cash (Debt)	-0.18	0.26	-1.05	0.35	-0.23	-0.3
Net Cash Per Share	-0.01	0.02	-0.15	0.05	-0.12	-0.25
Filing Date Shares Outstanding	11.74	11.74	5.78	5.11	3.08	1.17
Total Common Shares Outstanding	11.74	11.74	5.78	4.43	3.08	1.17
Working Capital	-0.79	-1.38	-1.84	-0.47	-2.92	-1.07
Book Value Per Share	-0.07	-0.12	-0.19	0.18	0.03	-0.92
Tangible Book Value	-0.79	-1.38	-1.09	0.79	0.09	-1.08
Tangible Book Value Per Share	-0.07	-0.12	-0.19	0.18	0.03	-0.92

Source: S&P Global Market Intelligence. Standard template. Financial Sources.